IRWD is trading 7.4% up at $4.80, extending a multi-day rebound from late June levels despite a lack of company-specific news.
- No fresh earnings, FDA, M&A, or major corporate announcements have been reported as of July 8, 2026.
- The upward move appears driven by short-term momentum and trader positioning, particularly as the broader market remains mildly negative.